Based on the numerous regulatory functions of carnitines and their esters in energy metabolism and mitochondrial function, we investigated possible efficacy of LC-ALC formulation on PCOS ovarian physiology and underlying mechanisms and whether the addition of PLC to LC and ALC would have more beneficial effects on PCOS ovaries. The gene discussed is HSPG2; the disease is polycystic ovary syndrome.